Which antibiotics are associated with Stevens-Johnson syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotics Associated with Stevens-Johnson Syndrome

Trimethoprim-sulfamethoxazole (TMP-SMX) carries the highest risk for Stevens-Johnson syndrome among antibiotics, followed by sulfonamides, beta-lactams (particularly amoxicillin-clavulanate), fluoroquinolones, cephalosporins, tetracyclines, macrolides, and vancomycin.

High-Risk Antibiotic Categories

Sulfonamides - Highest Risk

  • TMP-SMX represents the most notorious antibiotic for causing SJS/TEN 1, 2, 3, 4
  • The crude relative risk is substantially elevated at 172 in some populations 1
  • Risk is particularly elevated in HIV-positive patients 1
  • Sulfamethoxazole demonstrated the highest risk signal in recent pharmacovigilance analysis of 78,593 infected patients 4

Beta-Lactams - High Risk

Penicillins:

  • Amoxicillin shows significant risk association with SJS/TEN 4, 5
  • Amoxicillin-clavulanate (co-amoxiclav) is well-documented as a cause, even in patients with prior uneventful exposures 5
  • Piperacillin demonstrates positive risk signals 4

Cephalosporins:

  • Ceftriaxone, cefuroxime, and cefotaxime all show significant risk associations 4
  • These are commonly implicated in pediatric populations 3

Fluoroquinolones - Moderate to High Risk

  • Account for approximately 4% of SJS/TEN cases 6
  • Levofloxacin specifically documented in fatal cases, particularly in oncologically complex patients 6
  • Risk appears elevated in patients with hypoalbuminemia and advanced malignancy 6

Tetracyclines - Moderate Risk

  • Doxycycline and minocycline both show significant risk associations 4
  • Minocycline has been associated with more serious adverse events compared to other tetracyclines (8.8 cases per 100,000 patient-years) 1
  • Minocycline specifically linked to drug-induced lupus and DRESS syndrome 1

Macrolides - Moderate Risk

  • Azithromycin demonstrates positive risk signals 4, 7
  • Cases documented even in patients with concurrent SARS-CoV-2 infection 7
  • Erythromycin, clarithromycin also implicated 3

Glycopeptides

  • Vancomycin shows significant risk association in pharmacovigilance data 4

Aminoglycosides

  • Gentamicin demonstrates positive risk signals 4

High-Risk Patient Populations

Patients at elevated risk include:

  • Those with pneumonia, urinary tract infections, or sepsis (higher risk than respiratory tract infections) 4
  • Male patients may have higher risk than females with certain antibiotics 4
  • Oncologically complex patients, particularly those with advanced colorectal cancer, malignant ascites, and hypoalbuminemia 6
  • HIV-positive patients (especially with TMP-SMX) 1
  • Patients with end-stage renal disease 7
  • Pediatric patients (infections and drugs both important triggers) 3

Critical Clinical Considerations

Immediate action required:

  • Withdraw the suspected antibiotic immediately upon recognition - this decreases risk of death 3
  • Immediate discontinuation is mandatory if any sign of bullous or exfoliative skin rash develops 8

Timing of onset:

  • Most reactions occur within 8 days of drug initiation 6
  • Delayed-onset cases can occur even in elderly patients with prior uneventful exposures 5

Genetic susceptibility:

  • HLA-B*1502 testing recommended for South East Asian patients before carbamazepine (anticonvulsant, not antibiotic) 3
  • Consider genetic testing for severe cases where drug avoidance is medically compromising 3

Common Pitfalls to Avoid

  1. Do not dismiss prior safe exposures - patients can develop SJS/TEN even after multiple uneventful courses of the same antibiotic 5

  2. Do not confuse paracetamol/ibuprofen as causative - these are likely confounders given frequent use for prodromal symptoms, though rare reports exist 3

  3. Do not overlook infection as trigger - up to 50% of pediatric SJS/TEN cases are infection-induced (HSV, Mycoplasma pneumoniae) 3

  4. Do not delay specialist referral - delayed transfer to specialist units increases mortality 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.